Horie Ryouichi, Ishida Takaomi, Maruyama-Nagai Masae, Ito Kinji, Watanabe Mariko, Yoneyama Akiko, Higashihara Masaaki, Kimura Satoshi, Watanabe Toshiki
Department of Hematology, School of Medicine, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan.
Microbes Infect. 2007 May;9(6):721-8. doi: 10.1016/j.micinf.2007.02.017. Epub 2007 Feb 24.
C/EBPbeta plays a pivotal role in activation of human immunodeficiency virus type 1 (HIV-1) in monocytes/macrophages. However, mechanisms for functional regulation of C/EBPbeta remain uncharacterized. Previous studies indicated that NF-kappaB activation by tumor necrosis factor (TNF) receptor family, which activates TNF receptor associated factor (TRAF), induces HIV-1 expression. We found that TRAF signals activate HIV-1 LTR with mutations of NF-kappaB sites in promonocytic cell line U937, suggesting existence of an alternative HIV-1 activating pathway. In this study, we have characterized the signal transduction pathway of TRAF other than that leading to NF-kappaB, using U937 cell line, and its subline, U1, which is chronically infected by HIV-1. We show that signals downstream of TRAF2 and TRAF5 activate p38 MAPK, which directly phosphorylates C/EBPbeta, and that activation of p38 MAPK potently activates C/EBPbeta-mediated induction of HIV-1 gene expression. We also show TRAF2 and TRAF5 are expressed in monocytes/macrophages of spleen samples from HIV-1 infected patients. Identification of TRAF-p38 MAPK-CEBPbeta pathway provides a new target for controlling reactivation of latent HIV-1 in monocytes/macrophages.
C/EBPβ在单核细胞/巨噬细胞中人类免疫缺陷病毒1型(HIV-1)的激活过程中发挥着关键作用。然而,C/EBPβ功能调节的机制仍不清楚。先前的研究表明,肿瘤坏死因子(TNF)受体家族激活TNF受体相关因子(TRAF)从而激活NF-κB,可诱导HIV-1表达。我们发现,在原单核细胞系U937中,TRAF信号可激活具有NF-κB位点突变的HIV-1长末端重复序列(LTR),这表明存在另一种HIV-1激活途径。在本研究中,我们利用U937细胞系及其被HIV-1慢性感染的亚系U1,对TRAF除导致NF-κB之外的信号转导途径进行了表征。我们发现,TRAF2和TRAF5的下游信号激活p38丝裂原活化蛋白激酶(MAPK),其直接磷酸化C/EBPβ,并且p38 MAPK的激活有力地激活了C/EBPβ介导的HIV-1基因表达诱导。我们还发现,TRAF2和TRAF5在HIV-1感染患者脾脏样本的单核细胞/巨噬细胞中表达。TRAF-p38 MAPK-C/EBPβ途径的鉴定为控制单核细胞/巨噬细胞中潜伏HIV-1的重新激活提供了一个新靶点。